MOUNTAIN VIEW, Calif., Nov. 12, 2013 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq: VVUS ) today announced that management will present an overview of the company at the following investment conference:
| 2013 Credit Suisse Healthcare Conference |
| November 13, 2013, 11:00am MST |
| Phoenix, AZ |
A live webcast and 30-day archive of the presentations will be available at http://ir.vivus.com .
About VIVUS
VIVUS is a biopharmaceutical company commercializing and developing innovative, next-generation therapies to address unmet needs in obesity, sleep apnea, diabetes and sexual health. For more information about the company, please visit www.vivus.com .
Certain statements in this press release are forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. These statements may be identified by the use of forward-looking words such as "anticipate," "believe," "forecast," "estimate," "expect," "intend," "likely," "may," "plan," "potential," "predict," "opportunity" and "should," among others. There are a number of factors that could cause actual events to differ materially from those indicated by such forward-looking statements. VIVUS does not undertake an obligation to update or revise any forward-looking statements. Investors should read the risk factors set forth in VIVUS's Form 10-K for the year ending December 31, 2012, as amended by the Form 10-K/A filed on April 30, 2013 and by the Form 10-K/A filed on June 12, 2013, and periodic reports filed with the Securities and Exchange Commission.
VIVUS, Inc. Dana B Shinbaum Corporate Development & Investor Relations Investor Relations: The Trout Group Brian Korb 646-378-2923
